CareTech has made a strategic investment in Melo, supporting the next stage of its development, validation and growth. We look at what the investment means for clinical teams, the evidence behind Melo so far and what comes next.

Our co-founders, James Burch and James Chapman, and Dr Natali Farran of the Royal Hospital for Neuro-disability took a one-year service evaluation of Melo to NR-SIG-WFNR in Belfast and INS 2026 in Dublin.

Learn more about the key principles to outlining Clinical Best Practice in managing complex behaviours with Melo. As highlighted by the Royal Hospital for Neurodisability.

In October 2025, the National Institute for Health and Care Excellence (NICE) published new guidelines for Chronic Neurological Rehabilitation and Acquired Brain Injury. Click here to read more about the guidelines and how Melo supports these.

Melo was showcased to a global audience at the 2025 NR-SIG Conference in Australia. Click here to read more about our experience!

Listen to James Piercy from NIHR talk to James Chapman, co-founder of Decently, about Melo and how data can be used to better understand and improve people’s recovery journey following a brain injury….

Decently recently hosted a patient and public involvement session with the help from James Piercy, to begin to explore the potential for a Patient & Family version of Melo in the future.

Melo recently attended the 2024 Division of Neuropsychology summit, held in Edinburgh. Click here to read more about our experience!

Melo recently attended the 2024 “Conundrums in Neurorehabilitation” conference hosted by Elysium Healthcare. Click here to read more about our experience this year!

Melo recently attended the 2024 annual UKABIF summit. Click here to read more about our experience this year!

Following a successful 15 month evaluation at Salford Royal hospital (part of the Northern Care Alliance NHS FT) we are excited to share the results and impact Melo has had....

Melo has recently published a full report evaluating a 15month pilot at Salford Royal Hospital. Check out the full report here.

Melo was recently presented our work at the NR-SIG-WFNR 2024 conference in Coimbra, Portugal! Many thanks to Salford Royal’s neuropsychology research team for coming along with us.

Melo was recently showcased at the Ulster university’s Digital Mental Health and Wellbeing 2024 conference, alongside colleagues from Salford Royal’s neuropsychology team.

We are delighted to announce that we have recently secured an 18-month contract with Elysium Healthcare for the use of our behavioural management platform, Melo™

Decently recently hosted a patient and public involvement session with the help from James Piercey, to better understand life with a brain injury, and the needs of the people Melo is having an impact on.

Melo was recently showcased at the University of Manchester’s Advances in Data Science and AI conference - including one research poster we have been involved with in collaboration with Salford Royal’s research team.

Melo was recently showcased at the GM Neurorehabilitation & Integrated Stroke Delivery Network - including two research posters we have been involved with in collaboration with NCA NHS FT.